1 reports of this reaction
1.1% of all ANTACID TABLETS reports
#18 most reported adverse reaction
BLINDNESS is the #18 most commonly reported adverse reaction for ANTACID TABLETS, manufactured by Rising Pharma Holdings, Inc.. There are 1 FDA adverse event reports linking ANTACID TABLETS to BLINDNESS. This represents approximately 1.1% of all 92 adverse event reports for this drug.
Patients taking ANTACID TABLETS who experience blindness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLINDNESS is a less commonly reported adverse event for ANTACID TABLETS, but still significant enough to appear in the safety profile.
In addition to blindness, the following adverse reactions have been reported for ANTACID TABLETS:
The following drugs have also been linked to blindness in FDA adverse event reports:
BLINDNESS has been reported as an adverse event in 1 FDA reports for ANTACID TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLINDNESS accounts for approximately 1.1% of all adverse event reports for ANTACID TABLETS, making it a notable side effect.
If you experience blindness while taking ANTACID TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.